Serum parathyroid hormone levels predict hospitalization in outpatients of heart failure: a preliminary study

National Medical Journal of China

Volumn 93, Issue 28, 2013, Pages 2205-2208

  Wu, Gang Yong ^a   Zong, Gang Jun ^a   Chen, Jing Kai ^a   Chen, Man Qing ^a   Xia, Yang ^a   Wang, Xiao ^a   Wang, Lu Lu ^a   Shi, Yi Cheng ^a   Wang, Tian Xiao ^a   Wang, Xiao Ying ^a   Jin, Wei Dong ^b  

^a The 101 Hospital of Chinese PLA   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Heart failure, congestive; Hospitalization; Natriuretic peptide, brain; Parathyroid hormone

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PARATHYROID HORMONE;

AGE; ARTICLE; DIABETES MELLITUS; GENDER; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OUTPATIENT; PARATHYROID HORMONE BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; BLOOD; HEART LEFT VENTRICLE FUNCTION; RECEIVER OPERATING CHARACTERISTIC;

HEART FAILURE; HOSPITALIZATION; HUMANS; OUTPATIENTS; PARATHYROID HORMONE; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, LEFT;

EID: 84880972274     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.28.008     Document Type: Article

References (14)

1. Maisel A S, Krishnaswamy P, Nowak R M, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002, 347:161-167.
2. Christ M, Thuerlimann A, Laule K, et al. Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. Eur J Clin Invest, 2007, 37:834-841.
3. 2001, 17:253-254.
4. Hagström E, Ingelsson E, Sundström J, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail, 2010, 12:1186-1192.
5. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008, 29:2388-2442.
6. 2006: 187-205.
7. Carlstedt F, Lind L, Wide L, et al. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest, 1997, 27: 977-981.
8. Kociol R D, Horton J R, Fonarow G C, et al. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes-, data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail, 2011, 4:628-636.
9. Huang D J. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure. Chin Med J, 2009, 122:608-609.
10. Krum H, Jelinek M V, Stewart S, et al. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust, 2011, 194:405-409.
11. Russo de Boland A. Age-related changes in the response of intestinal cells to parathyroid hormone. Mech Ageing Dev, 2004, 125:877-888.
12. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J, 2004, 25:1776-1787.
13. Weber K T, Simpson R U, Carbone L D. Vitamin D and calcium dyshomoeostasis-associated heart failure. Heart, 2008, 94: 540-541.
14. Henry R M, Kostense P J, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int, 2002, 62:1402-1407.